鼻腔鳞状细胞癌区域复发:治疗启示
本研究回顾37例初治鼻腔鳞状细胞癌(NCSCC)患者,分析肿瘤学结局,重点关注颈部淋巴结处理与复发。3年无病生存率为63%。89%患者接受手术,局部复发率12%,颈部淋巴结复发率18%,多见于晚期肿瘤。尽管初诊时淋巴结转移罕见,但区域复发需在治疗和随访中重视。
要点
- NCSCC手术局部控制良好,全鼻切除后无局部复发。
- 初诊时颈部淋巴结转移罕见,但区域复发率18%。
- 晚期肿瘤患者需考虑颈部多模式治疗。
核心结论
- NCSCC患者可实现良好局部控制,尤其根治性切除后。
- 初诊时颈部淋巴结转移罕见,但区域复发需在治疗和随访中考虑。
- 晚期肿瘤患者可能需要颈部多模式治疗。
研究设计与样本
- 回顾性分析37例既往未治疗的鼻腔鳞状细胞癌患者。
- 分析人口学数据、肿瘤特征、治疗管理和临床结局。
主要发现
- 总体3年无病生存率为63%。
- 89%(n=33)患者接受手术治疗。
- 全鼻切除后无局部复发病例。
- 所有手术治疗患者中局部复发率为12%(n=4)。
- 45%(n=15)患者在肿瘤切除时行颈淋巴结清扫,仅6%(n=2)组织学证实初始淋巴结转移。
关键数值与推荐
- 颈部淋巴结复发率为18%(n=6),主要见于晚期肿瘤患者,尽管先前已治疗颈部。
临床怎么用
- NCSCC治疗以手术为主,追求根治性切除以获良好局部控制。
- 治疗计划和随访中应警惕区域淋巴结复发,尤其晚期肿瘤患者。
- 晚期肿瘤患者可考虑颈部多模式治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Surgery is the primary treatment option for squamous cell carcinomas of the nasal cavity (NCSCC). Nodal involvement is rare at the time of initial diagnosis, and the role of diagnostic neck dissection as well as potential adjuvant irradiation of the neck remains controversial. The objective of this study was to assess the oncologic outcomes of patients with NCSCC with special emphasis on cervical lymph node treatment and recurrence. METHODS: 37 previously untreated patients were included in this study. Demographic data, tumor characteristics, therapeutic management, and clinical outcome were analyzed. RESULTS: Patients with advanced stage tumors were slightly overrepresented in this study and overall 3-year disease-free survival was 63%. A surgical treatment approach was pursued in 89% (n=33) of patients. After total rhinectomy, there were no cases of local recurrence. Overall, 12% (n=4) of all surgically treated patients developed local recurrence. While in 45% of patients (n=15), neck dissection was performed at the time of tumor resection, initial lymph node metastasis was histologically confirmed in only 6% (n=2) of surgically treated patients. Cervical lymph node recurrence occurred in 18% (n=6) of patients, predominantly those with advanced stage tumors, despite prior treatment of the neck. CONCLUSION: Excellent local control is achievable for patients with NCSCC, especially with radical tumor resection. While cervical lymph node metastasis is rare at the time of diagnosis, regional lymph node recurrence needs to be taken into consideration when planning therapy and follow-up. Multimodal treatment of the neck may be required for patients with advanced stage tumors.
引用
- Hussain T, Mattheis S, Dominas N, et al. Regional recurrence in a case series of patients with carcinoma of the nasal cavity - therapeutic implications. Rhinology. 2017. PMID: 28888026. doi:10.4193/Rhin17.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。